Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination
Davide Raineri(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Annalisa Chiocchetti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giuseppe Cappellano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Nataša Kuštrimović(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Camilla Barbero Mazzucca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mattia Perazzi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Riccardo Bruna(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mattia Bellan(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 2
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge
|JAMA Network Open|2021|493
The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development
|The Journal of Experimental Medicine|2012|378